Patent classifications
A61M2205/3344
Device and method for automated emergency arterial sheath placement
Disclosed are devices and methods for automated emergency arterial cannulation. The device comprises a hand-held automated emergency arterial sheath placement device having a body with a handle and an actuator, and an arterial sheath placement head at the distal end of the handle body configured for placement against the patient's skin. The arterial sheath placement head includes an arterial sheath insertion device configured to advance an arterial needle, guide wire, and arterial sheath into a patient's artery upon sequential operation of the actuator. The arterial sheath placement head also includes a non-invasive artery locator configured to locate an artery into which the arterial sheath is intended to be placed. The arterial sheath placement head also preferably includes a Doppler gel and antiseptic needle, a local anesthetic needle, and a scalpel, all of which are likewise configured to advance from the upper body portion upon sequential operation of the actuator.
OXYGEN PRESSURE REGULATING DEVICE AND SYSTEM
An oxygen pressure regulating device (100) is disclosed. The device (100) comprises a housing (102) including an inlet port (104) and an outlet port (106), the housing (102) including: a spring unit (112) including a plate (116) placed in fluid communication with the inlet port (104), the plate (116) being configured to be moved when impinged upon by an oxygen stream at a first pressure received through the inlet port (104); a bellows arrangement (118); and a switch (146) configured to be activated to open the outlet port (106) for releasing the oxygen stream through the outlet port (106). Also disclosed is a system comprising the oxygen pressure regulating device (100), a laminar flow element and a second conduit.
Pressure relief for a catheter balloon device
A method of limiting an inflation system pressure for dilating a region of a patient's nasal sinus passageways. The method includes grasping an inflation device. The inflation device includes a syringe including a plunger slidably disposed within a barrel, a connector for fluidly connecting an outlet of the syringe with a surgical instrument balloon, and a mechanical pressure indicator associated with the syringe, the mechanical pressure indicator including a housing and an indicator body disposed within the housing. The method also includes delivering the surgical instrument balloon to a patient's paranasal sinus target area, operating the plunger within the barrel of the syringe to deliver pressurized fluid to the surgical instrument balloon, and transitioning the indicator body to extend outside of the housing when a predetermined inflation pressure of the surgical instrument balloon is reached.
Drug delivery systems and methods with back pressure sensing
Systems and methods for injecting a drug and detecting tissue induced back pressure are disclosed. A drug delivery system may include a reservoir filled or fillable with a drug, an administration member connected or connectable in fluid communication with the reservoir, a drive assembly, and a pressure sensor. The administration member may be configured for insertion into and subsequently retraction from a patient. The drive assembly may be configured to urge the drug from the reservoir to deliver a dose of the drug to the patient via the administration member. The pressure sensor may be configured to detect tissue back pressure during use of the drug delivery system, including after dose completion and prior to retraction of the administration member. The drug delivery system may be controlled in a manner that accounts for the tissue back pressure measurement.
DETERMINATION OF CARDIAC PARAMETERS FOR MODULATION OF BLOOD PUMP SUPPORT
The systems, devices, and methods presented herein use a blood pump to obtain measurements of cardiac function. The system can quantify the functioning of the native heart by measuring certain parameters/signals such as aortic pressure or motor current, then calculate and display one or more cardiac parameters and heart function parameters, such as left ventricular pressure, left ventricular end diastolic pressure, or cardiac power output. These parameters provide valuable information to a user regarding current cardiac function, as well as positioning and function of the blood pump. In some embodiments, the system can act as a diagnostic and therapeutic tool. Providing cardiac parameters in real-time, along with warnings about adverse effects and recommendations to support cardiac function, such as increasing or decreasing the volumetric flow rate of blood pumped by the device, administering pharmaceutical therapies, and/or repositioning the blood pump allow clinicians to better support and treat cardiovascular disease.
TREATMENT OF PULMONARY CANCERS USING AN ELECTRONIC BREATH ACTUATED DROPLET DELIVERY DEVICE
Methods for the treatment of pulmonary cancers (primary, secondary, metastatic, etc.) using an electronic breath actuated droplet delivery device to deliver a cancer therapeutic directly to the pulmonary system of a subject in need thereof is disclosed. An in-line droplet delivery device and related methods for delivering precise and repeatable dosages to a subject for pulmonary use is disclosed. The in-line droplet delivery device includes a housing, an ejector mechanism, and at least one differential pressure sensor. The in-line droplet delivery device is automatically breath actuated by the user when the differential pressure sensor senses a predetermined pressure change within housing. The in-line droplet delivery device is then actuated to generate a plume of droplets having an average ejected particle diameter within the respirable size range, e.g, less than about 5-6 μm, so as to target the pulmonary system of the user.
FORMULATIONS AND METHODS FOR DIRECT SODIUM REMOVAL IN PATIENTS HAVING HEART FAILURE AND/OR SEVERE RENAL DYSFUNCTION
A direct sodium removal (“DSR”) infusate regimen and methods of use are provided for removing sodium and reducing fluid overload in patients with severe renal dysfunction and/or heart failure, in which a patient has at least a first DSR session with a first DSR infusate having no or low sodium that is instilled into a patient's peritoneal cavity for a first dwell period to cause sodium and excess fluid to migrate to the patient's peritoneal cavity, and thereafter, the patient may undergo conventional dialysis to rebalance the patient's fluid and sodium levels.
Dialysis system having inductive heating
A dialysis fluid system includes a dialysis fluid inlet; a dialysis fluid outlet; a pump positioned and arranged to pump dialysis fluid through the dialysis fluid inlet and the dialysis fluid outlet; and an inductive heater located between the dialysis fluid inlet and the dialysis fluid outlet, the inductive heater including a fluid flowpath positioned and arranged to receive non-heated dialysis fluid from the dialysis fluid inlet and to output heated dialysis fluid to the a dialysis fluid outlet, a conductive heater element located within the fluid flowpath so as to be or act as a secondary coil of a transformer, and a primary coil of the transformer located outside of the fluid flowpath and positioned so as to magnetically induce a current into the conductive heater element, causing the conductive heater element and surrounding fluid to heat.
Maternal and fetal intrapartum safety monitor
In part, the disclosure relates to a safety monitor and related methods to evaluate and manage intrapartum uterine contractions induced or augmented by Pitocin or other contraction inducing agents. The systems and methods include measuring a contraction parameter that may include one or more of frequency, strength, and duration of uterine contractions through a measurement device connected to a monitor. The systems and methods are programmed to stop the pump-based administration of a contraction inducing agent. Various lock out protocols and control over the ability to re-start a given pump are also described herein.
FLUID FLOW CONTROL OF A BLOOD TREATMENT DEVICE
The invention relates to a blood treatment device, having the following:
a fluid line system (10) for guiding a fluid flow comprising a line portion (14), wherein the line portion (14) can be formed as a closed fluid system, and comprising at least one first concentrate supply line (26) for supplying a first concentrate solution; a fluid pump (11) for conveying the fluid in the fluid line system (10); a determining means (13; 23; 33; 29) for capturing a state of the fluid line system (10); a control unit for controlling the fluid flow; characterized in that the control unit is configured in such a way that the line portion (14) only forms a closed fluid system when the state captured by the determining means (13; 23; 33; 29) meets a predetermined condition.